Skip to main content
Log in

A novel method for modification of tumor cells with bacterial superantigen with a heterobifunctional cross-linking agent in immunotherapy of cancer

  • Protocol
  • Published:
Molecular Biotechnology Aims and scope Submit manuscript

Abstract

Bacterial superantigens (SAGs) bind to cognate Vβ elements of T-cell receptors on T-cells and to major histocompatibility complex (MHC) class II molecules on antigen-presenting cells to activate T-cell subsets expressing the Vβ elements. We examined the possibility that the direct binding of SAGs (staphylococcal enterotoxins B [SEB] and A [SEA]) to tumor cells decreases the toxicity of SAGs, and that antitumor immunity can be induced with the aid of T-helper-1 (Th1)-type cytokines and monokines released from T-cells and monocytes, respectively, by activation with SAGs. In this context, we have developed a general method for conjugating SEB and SEA directly to tumor cells with a heterobifunctional cross linking agent, N-(γ-maleimidobutyryloxy) sulfosuccinimide sodium salt. Using this method, we have succeeded in conjugating SEB to a sufficient extent as to induce strong tumor immunity. Both in vitro T-cell culture with SEB-bearing Meth A cells and in vivo immunization with SEB-bearing Meth A cells induce strong antitumor activity. These results suggest that the direct conjugation of SAGs including SEB and SEA to tumor cells is a powerful and useful method for immunotherapy of cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Marrack, P. and Kappler, J. (1990) The staphylococcal enterotoxins and their relatives. Science 248, 705–711.

    Article  PubMed  CAS  Google Scholar 

  2. Herman, A., Kappler, J. W., Marrack, P., and Pullen, A. M. (1991) Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9, 745–772.

    PubMed  CAS  Google Scholar 

  3. White, J., Herman, A., Pullen, A. M., et al. (1989) The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T-cells and clonal deletion in neonatal mice. Cell 56, 27–35.

    Article  PubMed  CAS  Google Scholar 

  4. Fraser, J. D. (1989) High-affinity binding of staphylococcal enterotoxin A and B to HLA-DR. Nature 339, 221–223.

    Article  PubMed  CAS  Google Scholar 

  5. Peavy, D. L., Adler, W. H., and Smith, R. T. (1970) The mitogenic effects of endotoxin and staphylococcal enterotoxin B on mouse spleen cells and human peripheral lymphocytes. J. Immunol. 105, 1453–1458.

    PubMed  CAS  Google Scholar 

  6. Carlsson, R. and Sjögren, H. O. (1985) Kinetics of IL-2 and interferon-γ production, expression of IL-2 receptors, and cell proliferation in human mononuclear cells exposed to staphylococcal enterotoxin A. Cell. Immunol. 96, 175–183.

    Article  PubMed  CAS  Google Scholar 

  7. Fischer, H., Dohlsten, M., Andersson, U., et al. (1990) Production of TNF-α and TNF-β by staphylococcal enterotoxin A activated human T-cells. J. Immunol. 144, 4663–4469.

    PubMed  CAS  Google Scholar 

  8. Shimizu, M., Yamamoto, A., Nakano, H., and Matsuzawa, A. (1996) Augmentation of antitumor immunity with bacterial superantigen, staphylococcal enterotoxin B-bound tumor cells. Cancer Res. 56, 3731–3736.

    PubMed  CAS  Google Scholar 

  9. Spero, L., Stefanye, D., Brecher, P. I., et al. (1965) Amino acid composition and terminal amino acids of staphylococcal enterotoxin B. Biochemistry 4, 1024–1030.

    Article  PubMed  CAS  Google Scholar 

  10. Huang, I-Y. and Bergdoll. M. S. (1970) The primary structure of staphylococcal enterotoxin B. III. The cyanogen bromide peptides of reduced and aminoethylated enterotoxin B, and the complete amino acid sequence. J. Biol. Chem. 245, 3518–3525.

    PubMed  CAS  Google Scholar 

  11. Mehrishi, J. N. and Grassetti, D. R. (1969) Sulphydryl groups on the surface of intact Ehrlich ascites tumour cells, human blood platelets and lymphocytes. Nature 224, 563–564.

    Article  PubMed  CAS  Google Scholar 

  12. Acha-Orbea, H. and Palmer, E. (1991) Mls-a retrovirus exploits the immune system. Immunol. Today 12, 356–361.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Motomu Shimizu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shimizu, M., Matsuzawa, A. & Takeda, Y. A novel method for modification of tumor cells with bacterial superantigen with a heterobifunctional cross-linking agent in immunotherapy of cancer. Mol Biotechnol 25, 89–94 (2003). https://doi.org/10.1385/MB:25:1:89

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/MB:25:1:89

Index Entries

Navigation